Asia
Shandong Lukang Pharmaceutical Wins Pre-Bid for Antibiotic Under China Drug Procurement Program
Shandong Lukang Pharmaceutical's (SHA:600789) vancomycin hydrochloride injection won a preliminary bid under China's drug procurement program, according to a Tuesday disclosure to the Shanghai bourse.The drug is an antibiotic injection indicated for methicillin-resistant Staphylococcus aureus, among other bacteria, the company said in its filing.Shandong Lukang's sales of the antibiotic reached 5.4 million yuan in 2025.
SHA:600789
